Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Clinical trial NCT03537599 · TERMINATED

Trial details

NCT number: NCT03537599
Sponsor: Sumithira Vasu
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Minimal Residual Disease Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia

Start date: 2020-01-10
Primary completion: 2021-08-04
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.